Assessing the Acceptability of Home Blood Monitoring for Patients With Cancer Who Are Receiving Systemic Anticancer Therapy From a Patient, Caregiver, and Clinician Perspective: Focus Group and Interview Study

BACKGROUND: Regular blood testing is an integral part of systemic anticancer therapy delivery. Blood tests are required before every administration of treatment to ensure that a patient is sufficiently well to receive it. Blood testing is burdensome for patients as they require either an extra visit...

Descripción completa

Detalles Bibliográficos
Autores principales: Vercell, Amy, Taylor, Sally, Yorke, Janelle, Dowding, Dawn
Formato: Online Artículo Texto
Lenguaje:English
Publicado: JMIR Publications 2023
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9862331/
https://www.ncbi.nlm.nih.gov/pubmed/36607709
http://dx.doi.org/10.2196/39815

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9862331/
https://www.ncbi.nlm.nih.gov/pubmed/36607709
http://dx.doi.org/10.2196/39815

Ejemplares similares